Envisagenics

When humanity set foot on the Moon, Margaret Hamilton’s code was running the mission. As the lead software engineer for NASA’s Apollo program, she developed the onboard software that made the Moon landing possible. Her work laid the foundation for reliable software systems. At Envisagenics, we celebrate trailblazers like Hamilton, whose contributions continue to inspire scientific and technological advancements. #WomensHistoryMonth #STEM #WomenInTech #ApolloProgram #Envisagenics

Dr. Marie Bernard has dedicated her career to advancing aging research, health equity, and diversity in biomedical science. A nationally recognized geriatrician and researcher, she has led efforts to improve healthcare for older adults, train future physicians, and make science more inclusive. Her leadership spans academic medicine, the VA healthcare system, and NIH, where she drove initiatives for diversity in research and equitable healthcare solutions. At Envisagenics, we celebrate pioneers like Dr. Bernard, whose work continues to shape a more inclusive future in science and medicine. #WomensHistoryMonth #WomenInSTEM #HealthEquity #DiversityInScience #Envisagenics 

Last week, our CEO, Maria Luisa Pineda, PhD., joined an expert panel, hosted by JLABS to discuss how leaders can navigate opportunities in the #lifesciences industry. She shared personal stories that show if you trust your expertise, do your research, and surround yourself with the right mentors, success will follow. A huge thank you to JLABS for hosting this energizing and inspiring event to remind us all to “keep pushing”! #WomenInBio #AIinLifeSciences #HealthcareInnovation #Leadership #Envisagenics #AI #ML #ArtificialIntelligence #MachineLearning #LifeSciences   

We’re #hiring a new Computational Biology Scientist in New York. Apply today or share this post with your network.

Envisagenics is thrilled to announce that our CEO, Maria Luisa Pineda, PhD., has been named an honoree of Inc. Magazine's 2025 #FemaleFounders500 (https://lnkd.in/ex4jJGAp)! This prestigious list recognizes the most inspiring women in business, and we couldn’t be prouder to see Maria Luisa Pineda, PhD.'s leadership and vision celebrated. Her dedication to advancing #AI-driven drug discovery and empowering innovation in #lifesciences continues to inspire us every day. Congratulations, Maria Luisa Pineda, PhD.! Read the full article here: https://lnkd.in/d_2CzDy #WomenInBio #AIinLifeSciences #HealthcareInnovation #Leadership #Envisagenics #AI #ML #ArtificialIntelligence #MachineLearning #LifeSciences 

On February 13th our CEO, Maria Luisa Pineda, PhD. joined an expert panel, hosted by MIT Sloan Alumni Club of New York and moderated by Stephanie Oestreich, Managing Director of Multiple Myeloma Research Foundation - MMRF to discuss how AI is transforming biotech, from early discovery to drug development. A huge thank you to MIT Sloan Alumni Club of New York for hosting with Kristopher Brown from Goodwin for this thought-provoking event! #AI #ML #ArtificialIntelligence #MachineLearning #LifeSciences #MIT #Biotech #RNAsplicing #MultipleMyeloma

Envisagenics is excited to welcome Sudhir Rao, MBA, M.S., as our new Chief Business Officer! Sudhir Rao brings extensive experience in biotech business development, strategic partnerships, and growth initiatives, with deep expertise in oncology, neurology, and immunology therapeutic areas. His leadership will be instrumental as we continue to advance our growing pipeline of promising AI-identified drug targets and novel therapeutics. Read the full press release here: https://rb.gy/d9rhi5 Join us in welcoming Sudhir Rao to the team! #Envisagenics #Biopharma #Biotech #AIinBiopharma #RNAtherapeutics

On February 10 at 4:00 PM, Envisagenics’ CEO, Maria Luisa Pineda, PhD., will join an expert panel at the BIO CEO & Investor Conference to dive into AI’s Utility in Pharmacokinetics and Biomarker Selection.   The discussion will feature Deirdre De Steno PhD MBA (Owkin) and Michael Foley (Excelsior Sciences), and moderated by Ricardo Vilanova (EY).   Join us for a deep dive into the cutting-edge of biotech innovation: https://lnkd.in/eB6H-5vE   #BIOCEO2025 #AIinHealthcare #BiotechInnovation #Pharmacokinetics #BiomarkerDiscovery #DrugDiscovery

Today, on #WorldCancerDay, Envisagenics stand united with the global community to advance the fight against cancer. At Envisagenics, we are proud to contribute to this mission by using our SpliceCore platform to uncover novel therapeutic targets through RNA splicing analysis. Our commitment goes beyond innovation—it’s about creating real, tangible hope for patients, their families, and the healthcare providers working tirelessly to save lives. Let’s work together to create a future where cancer is no longer a formidable opponent. Join us in raising awareness and championing innovation. Together, we can make a difference. #AIinBiotech #CancerResearch #WorldCancerDay #InnovationForLife #SpliceCore #Oncology #HopeThroughScience

Join Us at Women In Bio New York Metro event on February 6, 2025. Maria Luisa Pineda, PhD., CEO & Co-founder of Envisagenics, will be part of an exciting panel discussion with Jessily R.(CureAI Insights) and Logan Troppito (Accenture) on AI's disruptive and exhilarating impact on the life sciences industry. Moderated by Dr. Glennis Mehra (Biolabs@NYULangone), the conversation will explore the near-term status and future potential of AI in transforming life sciences—don't miss this chance to hear from industry leaders at the forefront of innovation. Register for the event here: https://lnkd.in/ef4sX6Nm #WomenInBio #AIinLifeSciences #HealthcareInnovation #Leadership #Envisagenics